A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects

Inclusion Criteria:

• Adult cataract patients aged 40 years and older scheduled for age related cataractsurgery in both eyes.

• Ability to understand and sign an ethics committee-approved informed consent form.

• Willingness and ability to attend all scheduled study visits as required by theprotocol.

• Postoperative potential visual acuity of 20/25 or better in each eye, as determinedby the investigator.

• Preoperative corneal astigmatism that can be corrected with a T3 or T4 toric IOL, orwith a spherical IOL and LRIs or AKs resulting in a predicted postoperativeastigmatism of less than 0.5 diopters (D).

• Ability to understand and complete questionnaires.

Exclusion Criteria:

• Women who are pregnant, planning to become pregnant during the study, orbreastfeeding.

• Ocular conditions that could confound study results, including moderate to severecorneal pathology, irregular astigmatism, moderate to severe dry eye, preexistingretinal diseases such as macular degeneration or diabetic retinopathy.

• Any form of confirmed glaucomatous damage (ie, mild, moderate, or severe glaucoma).

• Participation in another clinical study that could interfere with the results.

• Systemic conditions that may affect healing or visual outcomes (e.g., uncontrolleddiabetes mellitus, certain autoimmune disorders).

• Subjects with nystagmus, strabismus, zonular laxity or dehiscence, andpseudoexfoliation.

• Prior ocular surgery (except for uncomplicated cataract surgery in the fellow eye).

• Participants desiring monovision.

• Any active ocular infection or inflammation (except for routine post-operativeinflammation in the fellow eye)

• Psychiatric or cognitive disorders that may impair the ability to comply with studyprocedures or provide accurate self-assessments.

• RMS total higher-order aberrations (HOAs) >0.70 µm or coma >0.40 µm as measured bytomography or topography with a 4 mm pupil setting.